(Bloomberg) -- Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have ...
The pain drug will be marketed by the name of Journavx. Following the nod, Journavx has become the first and only non-opioid oral pain signal inhibitor and the first new class of pain medicine to ...
It aims to educate seniors about non-opioid alternative pain treatments and on ways to safely dispose of addictive painkillers. The Committee approved the Providing Reliable Options for Patients ...
(Alliance News) - Indivior PLC on Monday said the US Food & Drug Administration has approved label changes for its opioid use disorder treatment Sublocade, allowing for faster initiation and more ...
It aims to educate seniors about non-opioid alternative pain treatments and on ways to safely dispose of addictive painkillers. The Committee approved the Providing Reliable Options for Patients ...
The pain drug will be marketed by the name of Journavx. Following the nod, Journavx has become the first and only non-opioid oral pain signal inhibitor and the first new class of pain medicine to be ...